Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	694
Mentorship in the lives of scholars	423
Kidney health within the broader non-communicable disease agenda	378
Engineered CAR macrophages target kidney inflammation	355
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	328
Making advance care planning easier for adults with kidney disease and their clinicians	328
Role of the gut microbiota in the pathogenesis of IgA nephropathy	315
The GLP-1 receptor agonist revolution comes to nephrology	296
Uropathogen and host responses in pyelonephritis	241
Designing acute kidney injury clinical trials	228
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	226
Disaster preparedness for patients with kidney disease	209
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	189
Treatment of chronic kidney disease in older populations	187
Vaccination in patients with kidney failure: lessons from COVID-19	168
A single-cell atlas of DKD treatment responses	163
Daprodustat for anaemia in CKD	161
Roles of sensory receptors in non-sensory organs: the kidney and beyond	160
Beyond state borders: transforming dialysis care for undocumented immigrants	153
Genetic determinants of urine and plasma metabolite levels	150
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	149
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	146
Consideration of sex differences is necessary to achieve health equity	141
Complosome — the intracellular complement system	137
Phosphate sensing via PTC glycolysis	135

Mutational signatures of ccRCC vary between geographical regions	134
Reducing preventable acute kidney injury in a hospital setting	129
Bringing Pride to nephrology	129
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress	129
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	126
Clonal haematopoiesis and AKI	123
Increasing diversity and inclusion in nephrology clinical trials	123
The effects of sex hormone therapy on kidney function	118
Informing clinical decision making during a pandemic — a call for better preparedness	116
The roles of hyaluronan in kidney development, physiology and disease	114
Menopause and chronic kidney disease	113
Interferon blockade in lupus: effects on antiviral immunity	109
Aquaporin water channels: roles beyond renal water handling	109
Benefits of actin cytoskeleton stabilization	105
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	102
From mapping kidney function to mechanism and prediction	101
Identification of erythropoietin-producing cells	99
NUAK1 promotes kidney fibrosis	98
Design of a renal-sparing antifungal	95
Tertiary lymphoid organs contribute to kidney allograft rejection	93
Treatment of SLE with anti-CD19 CAR-T cells	92
Heat and health inequity: acting on determinants of health to promote heat justice	88
RNA-binding proteins and their role in kidney disease	82
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	81
From fat to filter: the effect of adipose tissue-derived signals on kidney function	80
The role of complement in kidney disease	80
Long-term health outcomes associated with hydration status	79
Salt substitution: opportunities and challenges for nephrology	77
Pathological mechanisms of kidney disease in ageing	74
Neutrophils and NETs in kidney disease	74
Reaping the rewards of mechanistic discovery in glomerular disease	70
The evolving landscape of immune-mediated glomerular diseases	70
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	70
A golden year of innovative kidney disease therapeutics	67
MSC therapy for diabetic kidney disease and nephrotic syndrome	65
An integrated approach towards a public health perspective on chronic kidney disease	65
Network medicine: an approach to complex kidney disease phenotypes	64
A pathway of osmotic stress-induced necroptosis	62
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	61
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	61
Reducing stress-induced CHOP is renoprotective	61
Combination therapy for kidney disease in people with diabetes mellitus	59
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	57
Self-reactive innate-like B-1 cells infiltrate grafts	56
Consequence of microvascular inflammation in transplantation	56
Ketogenic diet benefits in critically ill patients with sepsis	55
CKD-specific ASCVD risk prediction tools	53
Transcatheter mitral valve repair in patients with CKD	53
The cilia mechanosensation debate gets (bio)physical	53
Educating primary healthcare providers about kidney disease	50

GalNAc-T14-associated defects in B cell homing in IgA nephropathy	50
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	49
Consequences of famine and malnourishment on kidney health	49
Continuing kidney care in conflicts	45
Role of the cGAS–STING pathway in systemic and organ-specific diseases	45
Kidney complications of parasitic diseases	45
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	45
Gene therapy in a model of nephrotic syndrome	44
Dietary protection of proximal tubules in diabetes	43
Mechanism of B cell survival in lupus nephritis	43
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	41
Nephrology education and training in Africa	41
Targeting IL-1Ra to attenuate fungal infection	41
Multifaceted innovations needed to advance transplant nephrology	40
Mannose as a driver of γδ T cell kidney infiltration	39
Steps forward in the treatment of IgA nephropathy	38
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	38
Metabolic alterations in hereditary and sporadic renal cell carcinoma	37
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	37
The kidney is a novel target of metformin	37
Born too soon: lifelong kidney risks and the importance of early intervention	35
Chronic cardiovascular–kidney disorder: a new conceptual framework	35
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	34
Role of necroptosis in kidney health and disease	34
A guide to gene–disease relationships in nephrology	34
Epithelial cell states associated with kidney and allograft injury	34
Fasting induces structural and functional changes in the peritoneal membrane	32
A multidisciplinary approach to cardiorespiratory fitness in CKD	32
ALCAM–CD6 in lupus nephritis	31
Insights into the impact of pregnancy on kidney disease	30
Derivation of collecting duct organoids	30
Author Correction: Therapeutic advances in COVID-19	30
Renal nerves in physiology, pathophysiology and interoception	29
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	29
Fibroblast activation and heterogeneity in fibrotic disease	29
Strategies to achieve gender equity in nephrology	27
Tissue-resident memory T cells in the urogenital tract	27
The perils of misinformation: when health literacy goes awry	26
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	26
Leveraging data as a patient–scientist: frustrations and opportunities	26
Acute kidney injury in patients with burns	26
Switching off SOX9 for epithelial recovery after AKI	26
From big data to smart decisions: artificial intelligence in kidney risk assessment	26
The impact of intrauterine growth restriction and prematurity on nephron endowment	26
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	25
CD38 — a new target in renal immune disease	25
Crosstalk between glomeruli and tubules	24
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	22
Digital determinants of health: opportunities and risks amidst health inequities	22
Collagen formation, function and role in kidney disease	22
The genetics of kidney stone disease and nephrocalcinosis	22
Hope for resistant hypertension through BrigHTN and PRECISION	22
Impact of persistent conflict and destabilizing events on dialysis care	21
Nephrology and women’s health post-Roe v. Wade: we must do better	20
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	20
Chlorthalidone in advanced CKD	20
The impact of population ageing on the burden of chronic kidney disease	20
Pathogenic cellular and molecular mediators in lupus nephritis	18
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	18
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	17
Deep learning applications in digital pathology	17
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	17
Bridging the gap of referral to nephrology care	17
Podocyte-targeted therapies — progress and future directions	16
Multi-omics integration in the age of million single-cell data	16
Cellular senescence: the good, the bad and the unknown	15
Anti-tumour antibody-producing plasma cells disseminate from tertiary lymphoid structures	15
Use of kidneys from SARS-CoV-2 infected donors	15
P3H2 in glomerular basement membrane regulation	15
Increased PD1 signalling in kidney ageing	14
New evidence of the impact of mitochondria on kidney health and disease	14
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	14
Insights into glomerular function and disease pathogenesis	14
mTORC1 under the control of CB1R	14
Belzutifan: a novel therapy for von Hippel–Lindau disease	14
TRPM channels in health and disease	13
Vascular damage in systemic lupus erythematosus	13
Advances and challenges in kidney fibrosis therapeutics	13
New and emerging therapies for diabetic kidney disease	13
Progress towards solving the donor organ shortage	12

Gasdermins and pyroptosis in the kidney	12
Important roles of mechanical force and hydraulic pressure in kidney function	11
Thiazides in kidney transplant recipients: skin in the game	11
Pharmacogenomics in the clinic	11
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	11
Trained immunity: from kidney failure to organ transplantation	11
The evolving story of apolipoprotein L1 nephropathy: the end of the beginning	11
Managing climate change risks is imperative for human health	10
Inflammation and gut dysbiosis as drivers of CKD–MBD	10
The genetics and pathogenesis of CAKUT	10
SGLT2 inhibitors may prevent diabetes	10
Incorporating dementia screening in the care of patients with kidney disease	10
Diuretics in patients with chronic kidney disease	10
The impact of the Russian–Ukrainian war for people with chronic diseases	10
Cell and gene therapy for kidney disease	9
Cystatin C and the misdiagnosis of CKD in older adults	9
Targeting OSBPL7 restores cholesterol efflux	9
Clonal haematopoiesis, ageing and kidney disease	9
Electronic patient-reported outcomes in chronic kidney disease	9
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	9
Advancing gender equity to improve kidney care for women: a patient perspective	9
Patient involvement in nephrology research	8
ECM remodelling by ADAMTS12 in fibrosis	8
The role of lysosomes in metabolic and autoimmune diseases	8
Opioids for chronic pain management in patients with dialysis-dependent kidney failure	8
Youth-onset type 2 diabetes mellitus: an urgent challenge	8
Ferroptotic stress promotes the AKI to CKD transition	8
Progress in xenotransplantation: overcoming immune barriers	8
Disasters and kidney care: pitfalls and solutions	7
Epidemiology of haemodialysis outcomes	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	7
Advances in CRISPR therapeutics	6
VISTA dampens T cell activation in injured kidney	6
Intersectionality as a lens for achieving kidney health justice	6
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	6
Synchronization in the renal microcirculation	6
Remodelling by macula densa cells	6
Avenciguat reduces albuminuria in patients with chronic kidney disease	6
A guide to studying 3D genome structure and dynamics in the kidney	6
New insights into kidney crosstalk with distant organs	6
Kidney and heart failure outcomes associated with SGLT2 inhibitor use	6
Circulating osteopontin mediates acute kidney injury-induced respiratory failure	6
Long-term lessons from EMPA-KIDNEY	6
The pathogenesis of pre-eclampsia in kidney donors	6
Inequities in kidney health and kidney care	5
Including sexual orientation and gender identity data to advance nephrology care	5
Amino acid metabolism in kidney health and disease	5
Post-translational modifications in kidney diseases and associated cardiovascular risk	5
Paths to organ damage and risk factors in AKI	5
The catastrophic costs of chronic kidney disease	5
Removal of small, asymptomatic kidney stones	5
Drug repurposing for glomerular diseases: an underutilized resource	5
The intelligent podocyte: sensing and responding to a complex microenvironment	5
Diagnosis of cardiovascular disease in patients with chronic kidney disease	5
UTX regulates accumulation of lipids via kidney serine	4
Sex differences in kidney metabolism and DKD	4
Sexual orientation and gender identity in organ and tissue donation and transplantation	4
The roles of tertiary lymphoid structures in chronic diseases	4
Overcoming barriers to deliver high quality kidney care	4
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	4
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	4
A polygenic score predicts CKD across ancestries	4
The kidney stroma in development and disease	4
AngII autoantibodies after SARS-CoV-2 infection	4
Leveraging lysine metabolism for renoprotection	4
Association of metabolic dysfunction-associated fatty liver disease with kidney disease	4
Iron deficiency of kidney macrophages in CKD	4
Targeting iron uptake to correct T cell dysfunction	4
Ensuring health equity for sexual and/or gender minority individuals	4
Improving nephrology care for people with cognitive impairments and their caregivers	4
Neuroprotective effect of RAS inhibitors	4
NCKs are essential to podocyte–GBM interactions	4
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells	3
Spatial transcriptomics in health and disease	3
Collagen IV in Gould syndrome and Alport syndrome	3
Long COVID: long-term health outcomes and implications for policy and research	3
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	3
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects	3
Author Correction: The immunoregulatory roles of non-haematopoietic cells in the kidney	3
Targeting APRIL to slow progression of IgA nephropathy	3
Insights into basement membrane complexity	3
Managing RAAS inhibitor use in advanced CKD	3
Macrophages clean out the tubules	3
Propagation of acute kidney injury	3
The pathogenesis of IgA nephropathy and implications for treatment	3
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants	3
The global landscape of kidney registries: immense challenges and unique opportunities	3
VHL loss attracts immune cells to tumours	3
Nanocapsule system tackles polymyxin B toxicity	3
Benefits of CoQ10 supplementation in patients with SRNS due to primary CoQ10 deficiency	3
Kidney benefits of SLGT2 inhibitors: evidence from clinical trials	3
Protein handling in kidney tubules	3
Artificial intelligence approaches to enable early detection of CKD	3
Chronic kidney disease screening in LMICs: benefits and challenges	3